Is XBIT or XENE more undervalued in 2026?

CirclFi compares XBiotech Inc. (XBIT) and Xenon Pharmaceuticals Inc. (XENE) using 13 institutional-grade valuation models. XBIT has a Quality of Company score of 4.7/10 while XENE scores 5.4/10.

Which is a better buy — XBIT or XENE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do XBIT and XENE valuations compare?

XBIT at $2.44 and XENE at $54.79 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

XBIT vs XENE Valuation Comparison 2026 — Intrinsic Value Analysis

XBIT

Biotechnology

XBiotech Inc.

Quality

4.7

out of 10

Value Trap

SAFE

Price

$2.44

Last close

Models

7/13

Active

XENE

Biotechnology

Xenon Pharmaceuticals Inc.

Quality

5.4

out of 10

Value Trap

LOW

Price

$54.79

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	XBIT Fair Value	XBIT Upside	XENE Fair Value	XENE Upside
Bayesian DCF	Intrinsic	$2.56	+4.8%	$19.57	-64.3%
Earnings Power Value	Intrinsic	—	—	$24.80	-55.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$4.70	+92.6%	$12.80	-76.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for XBIT vs XENE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

XBIT vs XENE — Which Stock Is More Undervalued?

XENE scores higher with a 5.4/10 quality rating vs XBIT's 4.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing XBiotech Inc. (XBIT) and Xenon Pharmaceuticals Inc. (XENE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

XBIT currently trades at $2.44 with a QOC of 4.7/10, while XENE trades at $54.79 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).